RELATED PARTY TRANSACTIONS (Details Textual) (USD $)	1 Months Ended						3 Months Ended	6 Months Ended	12 Months Ended					6 Months Ended					1 Months Ended		3 Months Ended	1 Months Ended						1 Months Ended
	Apr. 30, 2013	Nov. 30, 2012	Aug. 31, 2012	Jun. 30, 2012	Apr. 30, 2012	Mar. 31, 2012	Mar. 31, 2013	Jun. 30, 2013	Dec. 31, 2012	Jan. 31, 2013	Sep. 30, 2012	Aug. 13, 2012	Mar. 28, 2012	Jun. 30, 2013 Minimum [Member]	Jun. 30, 2013 Maximum [Member]	Mar. 28, 2012 First Advance [Member]	Mar. 28, 2012 Second Advance [Member]	Dec. 31, 2008 Related Party [Member]	Aug. 31, 2012 Samuel Herschkowitz [Member]	Apr. 30, 2012 Samuel Herschkowitz [Member]	Mar. 31, 2012 Samuel Herschkowitz [Member]	Apr. 30, 2012 Samuel Herschkowitz [Member] Minimum [Member]	Apr. 30, 2012 Samuel Herschkowitz [Member] Maximum [Member]	May 31, 2012 Sok Partners [Member]	Mar. 31, 2012 Sok Partners [Member]	Dec. 31, 2012 Sok Partners [Member]	Mar. 14, 2012 Sok Partners [Member] Common Stock [Member]	Mar. 31, 2012 Dr Herschkowitz and Sok Partners Llc [Member]	Jun. 30, 2012 Board of Directors Chairman [Member]	Jun. 30, 2012 Director [Member]
Payments Made To Officers One																													$ 25,000
Proceeds from Issuance or Sale of Equity									3,000,000
Payments Made To Officers Two																														30,000
Related Party Transaction, Due from (to) Related Party				2,000														46,000
Accounts Payable, Related Parties									10,000
Converible Note Percentage		20.00%	20.00%			20.00%
Converible Note Principal Amount		156,243	600,000			240,000
Notes Payable, Total																										357,282
Debt Instrument, Convertible, Effective Interest Rate										8.00%	24.00%
Advance Under Note																300,000	84,657							300,000	300,000
Cash Advance Net Of Interest													60,000
Debt Instrument, Convertible, Conversion Price	$ 0.10									$ 0.12			$ 0.065
Stock Issued During Period, Shares, Conversion of Units																								4,615,385	4,615,385
Stock Issued During Period, Value, Conversion of Units						600,000
Stock Issued During Period, Shares, Other						1,546,667
Stock Transferred During Period					7,500,000
Shares Issued Related Party Transactions One				277,778
Price Per Share Related Party Transactions				$ 0.09
Compensation Issued In Lieu Of Cash				25,000
Warrants Shares Related Party Transactions				30,000
Warrants Price Per Share Related Party Transactions				$ 0.15
Shares Issued Related Party Transactions Two																			26,500,000
Debt Instrument Convertible Conversion Price Minimum												$ 0.014
Debt Instrument Convertible Conversion Price Maximum												$ 0.065
Shares Issued Related Party Transactions Three		1,562,430
Proceeds from Related Party Debt		155,000
Convertible Note Due Date	Aug. 31, 2013						Apr. 30, 2013
Related Party Transaction, Description of Transaction								financing raising not less than $1 million, compensation of $75,000; (ii) a going private transaction, compensation of $200,000 and (iii) 3% of the gross proceeds of the NASDAQ underwriting, which payment shall under no circumstances be less than $200,000 or greater than $3,000,000. In May 2013 Dr. Herschkowitz received $75,000 after the Company surpassed raising $1 million.
Equity Bonus Valued At Common Stock Rate																									$ 0.065
Additional Issue Of Common Stock Shares																											16,000,000
Stock Issued During Period Shares New Issues	1,041,622	357,163						543,292												7,500,000					13,250,000			13,250,000
Percentage Of Interest Rate On Event Of Default																						20.00%	24.00%
Percentage Of Accrued Interest																					20.00%
Proceeds From Offering Of Securities														$ 2,000,000	$ 4,000,000
Compensation Payment Pursuant To Merger							listing the Companys shares on NASDAQ pursuant to an underwritten offering of the Companys securities resulting in gross proceeds of between $5 million and $30 million then the Company shall deliver to Dr. Herschkowitz the following compensation: (A) $75,000 upon consummating the shell merger, (B) $150,000 upon consummating the qualifying financing round and (C) 3% of the gross proceeds of the NASDAQ underwriting, which payment shall under no circumstances be less than $200,000 or greater than $1,000,000. The Company shall reimburse Dr. Herschkowitz at his actual out-of-pocket cost for reasonable expenses incurred in connection with the shell transactions but in no event in an amount greater than $10,000.